Open Access 01-07-2018 | Original Article
Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
Published in: Clinical Rheumatology | Issue 7/2018
Login to get access